Passage of blood-brain barrier: free [6] . Propranolol has a highest degree of lipid solubility, compared with other β-blockers, which enables it to penetrate the BBB and to accumulate in the brain.
Elimination half-life: 2 to 3 h, prolonged up to 14 h at overdose [4] .
Metabolism and excretion
Propranolol is completely metabolized. It is efficiently extracted during the first pass through the liver, where it is biotransformed, with production of several active metabolites. One of them is 4-hydroxypropranolol, which has β-blocking activity comparable to that of propranolol, and is present in plasma after oral administration of the drug, but has a shorter half-life than a parental drug. Other metabolites are norpropranolol and α-naphthoxy-2,3-propyleneglycol. Their biological activity is very low compared to that of a parental drug [2, 3, 4] .
Excretion: about 84-92% of an oral dose is excreted in the 48 h urine, with 20% as naphthoxylactic acid, up to 25% as propranolol glucuronide and only about 0.5% of unchanged drug [2, 4] .
Mechanisms of action
Propranolol inhibits the action of catecholamines, especially of epinephrine, on both β 1 -and β 2 -adrenergic receptors, and decreases its level in the CNS and in blood. This leads to a lowering of blood pressure and to suppressing of cardiac arrhythmias [3] .
Toxicological mechanisms
Toxic effect of propranolol at the overdosing is possibly associated with its fast accumulation in the brain, leading to the CNS collapse [3] .
Target organs: CNS, liver, kidney [6] .
